Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to fall 103.88% to -1 cents per share on July 30
Q2'26
Est.
$-0.01
Q1'26
Beat
by $0.37
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.04
Q2'25
Beat
by $0.02
The last earnings report on May 05 showed earnings per share of 33 cents, beating the estimate of -3 cents. With 2.84M shares outstanding, the current market capitalization sits at 302.99M.